Scientists say they've extracted bone marrow from fossilized frogs and salamanders that died 10 million years ago in the swamps of northeastern Spain.
The first fossilized bone marrow known to science was discovered in remarkable detail, the BBC reported, and provides scientists with possible traces of organic molecules, protein and even, possibly, DNA.
Bone marrow is the tissue that fills the center of large bones, producing platelets and red and white blood cells. Scientists are studying the material for traces of organic molecules, protein and DNA.
"Finding soft tissue like this is so important because it gives an insight into the physiology of ancient organisms, and how their bodies worked," Maria McNamara of University College Dublin told the BBC. "The fact that we've got red bone marrow in the salamander shows their blood cells were produced in the bone marrow; in the modern salamander it is not, it is produced in the spleen."
An initial report on the discovery appears in the journal Geology.
Copyright 2006 by United Press International
Related stories:
T. rex had teen pregnancies
Dinosaurs descended from reptiles and evolved into today's birds, but their growth and sexual maturation were more like that of mammals - complete with teen pregnancy, according to a new study by University of California, Berkeley, scientists.
On the trail of a targeted therapy for blood cancers
Investigators from the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine are focusing on a family of blood proteins that they hope holds a key to decreasing the toxic effects of chemotherapy in children and adults.
Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
Essential for life in higher animals, vitamin D, once linked to only bone diseases such as rickets and osteoporosis, is now recognized as a major player in contributing to overall human health, emphasizes UC Riverside's Anthony Norman, an international expert on vitamin D.
Time of day influences yield for pharmacologically stimulated stem cell mobilization
A new study uncovers a previously unrecognized, species-specific impact of circadian rhythms on the production of mobilized stem cells. The research, published by Cell Press in the October 9th issue of the journal
Cell Stem Cell, suggests that when it comes to collecting human stem cells for clinical transplantation, picking the right time of day to harvest cells may result in a greater yield.
Scientists pinpoint key proteins in blood stem cell replication
A family of cancer-fighting molecules helps blood stem cells in mice decide when and how to divide, say researchers at the Stanford University School of Medicine. Blocking the molecules' function spurs the normally resting cells to begin proliferating strangely - making too much of one kind of cell and not enough of another. Many types of human blood cancers involve a similar disruption in the expression of that same family of molecules.
Can stem cells heal damaged hearts? No easy answers, but some signs of hope
Recent studies indicate that infusing hearts with stem cells taken from bone marrow could improve cardiac function after myocardial infarction (tissue damage that results from a heart attack). But in a recent systematic review, Cochrane Researchers concluded that more clinical trials are needed to assess the effectiveness of stem cell therapies for heart patients, as well as studies to establish how these treatments work.
New Stanford diagnostic test for rare leukemia appears to give faster results, study finds
A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukemias in hours instead of weeks, according to a study by researchers at the Stanford University School of Medicine and UC-San Francisco. The clinical promise of the Stanford-developed approach, which eavesdrops on individual cells to decipher potentially dangerous molecular conversations, is likely to extend to many other disorders in which cell-signaling pathways are disrupted.
Scientists develop new, more sensitive nanotechnology test for chemical DNA modifications
Researchers at The Johns Hopkins University School of Medicine in Baltimore have developed a novel test to screen for chemical modifications to DNA known as methylation. The technology potentially could be used both for early cancer diagnoses and for assessing patients' response to cancer therapies.